12 Triple agonists further integrate appetite suppression, insulin sensitization, and increased energy expenditure, theoretically offering the most comprehensive metabolic effects among incretin-based therapies
Vitamin C and citrus essential oils may cause sensitivity
Retatrutide is an investigational triple agonist that simultaneously activates glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon receptors
After adding the diluent, gentle swirling (never shaking) dissolves the peptide while maintaining its structural integrity
This is particularly important for peptides accessed multiple times
BPC-157 (Capsules) Body Protection Compound CAS: 137525-51-0 Formula: C 62 H 98 N 16 O 22 M.W.: 1419.5347 g/mol Purity: 99%+ HPLC Verified Ref No.:BPC-0250TA Ref No.:BPCC-0500TA For Research Use Only (RUO) Not for human or veterinary use